Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-23

Clinical Trial Update: Hydrocortisone 50 mg Every 6 Hours Compared to Hydrocortisone 300 mg Per Day in Treatment of Septic Shock. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing hydrocortisone dosing regimens (50 mg every 6 hours vs 300 mg per day) for septic shock; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: Association Niçoise de Réanimation Médicale | Conditions: Septic Shock | Phase 4 | Status: COMPLETED